KIR matching in hematopoietic stem cell transplantation
- PMID: 16085405
- DOI: 10.1016/j.coi.2005.07.014
KIR matching in hematopoietic stem cell transplantation
Abstract
Although the key role of MHC-restricted T lymphocytes in hematopoietic stem cell transplantation (HSCT) has been known for a long time, recent data have focused on complementary or alternative effector cell populations, and in particular on NK cells. Spontaneously generated NK cell alloreactivity from stem cell grafts involves specific interactions between NK receptors, including killer immunoglobulin-like receptors (KIRs) and their MHC class I ligands. The combined effects of HLA and KIR polymorphic genes might explain discrepancies in the impact of donor-recipient matching observed in HSCT.
Similar articles
-
The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.Transpl Immunol. 2005 Aug;14(3-4):203-6. doi: 10.1016/j.trim.2005.03.008. Transpl Immunol. 2005. PMID: 15982564 Review.
-
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.Tissue Antigens. 2004 Mar;63(3):204-11. doi: 10.1111/j.0001-2815.2004.00182.x. Tissue Antigens. 2004. PMID: 14989709
-
Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant. 2008 Apr;41(8):709-14. doi: 10.1038/sj.bmt.1705954. Epub 2008 Jan 14. Bone Marrow Transplant. 2008. PMID: 18195688
-
Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.Biol Blood Marrow Transplant. 2010 Apr;16(4):469-81. doi: 10.1016/j.bbmt.2009.12.008. Epub 2010 Jan 4. Biol Blood Marrow Transplant. 2010. PMID: 20044012
-
Role of KIRs and KIR ligands in hematopoietic transplantation.Curr Opin Immunol. 2008 Oct;20(5):581-7. doi: 10.1016/j.coi.2008.07.004. Epub 2008 Aug 23. Curr Opin Immunol. 2008. PMID: 18675345 Review.
Cited by
-
Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model.Cancer Immunol Immunother. 2008 May;57(5):655-62. doi: 10.1007/s00262-007-0404-2. Epub 2007 Sep 22. Cancer Immunol Immunother. 2008. PMID: 17891395 Free PMC article.
-
Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours.J Neurooncol. 2014 Jan;116(1):1-9. doi: 10.1007/s11060-013-1265-5. Epub 2013 Oct 2. J Neurooncol. 2014. PMID: 24085644 Free PMC article. Review.
-
Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?Curr Hematol Malig Rep. 2015 Mar;10(1):45-58. doi: 10.1007/s11899-014-0246-x. Curr Hematol Malig Rep. 2015. PMID: 25700678 Free PMC article. Review.
-
Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.Cancer Immunol Immunother. 2009 Jun;58(6):855-65. doi: 10.1007/s00262-008-0601-7. Epub 2008 Oct 8. Cancer Immunol Immunother. 2009. PMID: 18841361 Free PMC article.
-
A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs.Bone Marrow Transplant. 2009 Apr;43(7):525-32. doi: 10.1038/bmt.2008.352. Epub 2008 Nov 24. Bone Marrow Transplant. 2009. PMID: 19029967 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials